M.E. Smith

Related Content

• Vikings unveil stadium design: Top 10 tweets
  May 14, 2013
• Minneapolis labels adapt to postage hikes
  April 2, 2013
• "Download martyr" Jammie Thomas-Rasset out of legal options; $220,000 judgment stands
  March 19, 2013
• Post Office apologizes for returning woman's letter to Iraq-based son with "DECEASED" stamp
  February 15, 2013
• 10,000 Minutes of Minnesota Craft Beer 2013: Monday Events
  May 13, 2013

More About

• John Grisham
• Erin Smith
• Grant Adams
• Prescription Drugs
• Health Care Issues

Husband-wife author duo Matt and Erin Smith, writing under a single name, do for the pharmaceutical industry what John Grisham did for law. In their novel, Trials: The Risk/Benefit Ratio, the local writers tell the story of Grant Adams, a researcher whose daughter is ill with bronchiosclerosis. Grant takes a job with a small Minnesota pharmaceutical company that just happens to be developing a new "miracle drug" and looking for trial participants. But Grant soon discovers that the company is steeped in sinister ambition. He becomes tangled among professional and moral research violations, and murder. The authors tell the story of the money-hungry few on top of the drug industry, willing to bend any rule and stake any life to get a drug on the market. While the company makes plans to transition to public ownership and earn more and more money, Smith follows a family whose son's lungs thicken, harden, and eventually succumb to the illness. As Grant investigates his employers more deeply, the facts get uglier, and ultimately he is left with a choice: blow the whistle on a corrupt company, or shut up and hope his daughter benefits from the drug trial. Who knew prescription drug research could be so thrilling?
Thu., April 3, 4 p.m., 2008